Detalles de la búsqueda
1.
International Survey on Frailty Assessment in Patients with Cancer.
Oncologist
; 27(10): e796-e803, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35905085
2.
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy.
Cancer Invest
; 40(5): 406-412, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34409906
3.
Assessing the role of colonic and other anatomical sites uptake by [18 F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors.
Thorac Cancer
; 14(24): 2473-2483, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442801
4.
First-line immunotherapy in non-small cell lung cancer: how to select and where to go.
Expert Rev Respir Med
; 17(12): 1191-1206, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294292
5.
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Front Endocrinol (Lausanne)
; 14: 1065599, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793289
6.
Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.
Int Immunopharmacol
; 110: 108985, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35777264
7.
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.
Front Oncol
; 11: 643155, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34221963
8.
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy.
Clin Genitourin Cancer
; 19(5): 396-404, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849811
9.
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm.
Oncol Rev
; 14(2): 490, 2020 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32782728
10.
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab.
Transl Lung Cancer Res
; 9(4): 1533-1542, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953525
11.
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%.
J Immunother
; 43(9): 299-306, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991393
Resultados
1 -
11
de 11
1
Próxima >
>>